Annual Accounts Receivable
$27.42 M
+$11.92 M+76.85%
December 31, 2023
Summary
- As of February 22, 2025, ADMA annual accounts receivable is $27.42 million, with the most recent change of +$11.92 million (+76.85%) on December 31, 2023.
- During the last 3 years, ADMA annual accounts receivable has risen by +$14.18 million (+107.15%).
- ADMA annual accounts receivable is now -4.04% below its all-time high of $28.58 million, reached on December 31, 2021.
Performance
ADMA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$50.14 M
+$20.03 M+66.51%
September 30, 2024
Summary
- As of February 22, 2025, ADMA quarterly accounts receivable is $50.14 million, with the most recent change of +$20.03 million (+66.51%) on September 30, 2024.
- Over the past year, ADMA quarterly accounts receivable has increased by +$18.82 million (+60.10%).
- ADMA quarterly accounts receivable is now at all-time high.
Performance
ADMA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ADMA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +76.8% | +60.1% |
| 3 y3 years | +107.2% | +223.4% |
| 5 y5 years | +1869.3% | +223.4% |
ADMA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.0% | +76.8% | at high | +223.4% |
| 5 y | 5-year | -4.0% | +690.3% | at high | +1345.0% |
| alltime | all time | -4.0% | -100.0% | at high | -100.0% |
ADMA Biologics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $50.14 M(+66.5%) |
| Jun 2024 | - | $30.11 M(-39.3%) |
| Mar 2024 | - | $49.62 M(+81.0%) |
| Dec 2023 | $27.42 M(+76.9%) | $27.42 M(-12.4%) |
| Sep 2023 | - | $31.32 M(-14.7%) |
| Jun 2023 | - | $36.73 M(+38.5%) |
| Mar 2023 | - | $26.52 M(+71.0%) |
| Dec 2022 | $15.51 M(-45.7%) | $15.51 M(-25.8%) |
| Sep 2022 | - | $20.90 M(+10.7%) |
| Jun 2022 | - | $18.88 M(-26.3%) |
| Mar 2022 | - | $25.63 M(-10.3%) |
| Dec 2021 | $28.58 M(+115.9%) | $28.58 M(+40.1%) |
| Sep 2021 | - | $20.39 M(-13.4%) |
| Jun 2021 | - | $23.54 M(+53.3%) |
| Mar 2021 | - | $15.36 M(+16.1%) |
| Dec 2020 | $13.24 M(+281.5%) | $13.24 M(+109.0%) |
| Sep 2020 | - | $6.33 M(-2.8%) |
| Jun 2020 | - | $6.51 M(-8.4%) |
| Mar 2020 | - | $7.11 M(+104.8%) |
| Dec 2019 | $3.47 M(+149.2%) | $3.47 M(-52.6%) |
| Sep 2019 | - | $7.32 M(+43.8%) |
| Jun 2019 | - | $5.09 M(+288.2%) |
| Mar 2019 | - | $1.31 M(-5.9%) |
| Dec 2018 | $1.39 M | $1.39 M(-66.3%) |
| Sep 2018 | - | $4.13 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $3.80 M(+3.8%) |
| Mar 2018 | - | $3.66 M(-5.7%) |
| Dec 2017 | $3.88 M(+281.2%) | $3.88 M(+158.7%) |
| Sep 2017 | - | $1.50 M(-34.6%) |
| Jun 2017 | - | $2.29 M(+172.9%) |
| Mar 2017 | - | $839.90 K(-17.5%) |
| Dec 2016 | $1.02 M(+10.1%) | $1.02 M(-23.3%) |
| Sep 2016 | - | $1.33 M(+60.6%) |
| Jun 2016 | - | $826.70 K(-12.4%) |
| Mar 2016 | - | $943.90 K(+2.1%) |
| Dec 2015 | $924.50 K(+140.8%) | $924.50 K(-23.0%) |
| Sep 2015 | - | $1.20 M(+129.8%) |
| Jun 2015 | - | $522.50 K(+48.7%) |
| Mar 2015 | - | $351.40 K(-8.5%) |
| Dec 2014 | $384.00 K(>+9900.0%) | $384.00 K(-31.7%) |
| Sep 2014 | - | $562.20 K(-30.0%) |
| Jun 2014 | - | $803.50 K(+65.9%) |
| Mar 2014 | - | $484.40 K(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2013 | - | $335.10 K(+41.5%) |
| Jun 2013 | - | $236.90 K(-27.4%) |
| Mar 2013 | - | $326.30 K(+734.5%) |
| Dec 2012 | $39.10 K | $39.10 K(-36.8%) |
| Sep 2012 | - | $61.90 K(-71.9%) |
| Jun 2012 | - | $220.10 K |
FAQ
- What is ADMA Biologics annual accounts receivable?
- What is the all time high annual accounts receivable for ADMA Biologics?
- What is ADMA Biologics annual accounts receivable year-on-year change?
- What is ADMA Biologics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ADMA Biologics?
- What is ADMA Biologics quarterly accounts receivable year-on-year change?
What is ADMA Biologics annual accounts receivable?
The current annual accounts receivable of ADMA is $27.42 M
What is the all time high annual accounts receivable for ADMA Biologics?
ADMA Biologics all-time high annual accounts receivable is $28.58 M
What is ADMA Biologics annual accounts receivable year-on-year change?
Over the past year, ADMA annual accounts receivable has changed by +$11.92 M (+76.85%)
What is ADMA Biologics quarterly accounts receivable?
The current quarterly accounts receivable of ADMA is $50.14 M
What is the all time high quarterly accounts receivable for ADMA Biologics?
ADMA Biologics all-time high quarterly accounts receivable is $50.14 M
What is ADMA Biologics quarterly accounts receivable year-on-year change?
Over the past year, ADMA quarterly accounts receivable has changed by +$18.82 M (+60.10%)